The most useful opening question for Contour Health is not simply “What does a month cost?” It is “What exactly will I receive, what will I pay for that vial, and what happens afterward?” The company advertises weight-loss treatment without a subscription, but expresses prices in weekly and monthly amounts. Its weight-loss page also gives two different semaglutide starting prices and describes vial duration in different ways. Those differences make a written, individualized quote more useful than the headline price.
This documentary review examines Contour Health’s public pages consulted October 19, 2026, with an emphasis on preparing adults for a consultation rather than choosing treatment for them. The documented offering includes compounded injectable semaglutide and tirzepatide, clinician follow-up and pharmacy delivery. Strengths include named clinical leadership and specific contact routes. Questions remain about the final vial charge, delivery-problem remedies and conflicting eligibility language. The discussion below separates the company’s service promises from independently established clinical context.
At a glance
- Documented treatment
- Contour Health advertises compounded semaglutide and tirzepatide as once-weekly injections for weight management; these compounded preparations are not FDA approved.
- Starting-price discrepancy
- The weight-loss pricing table lists compounded semaglutide starting at $30 per week, while its calculator lists semaglutide from $25 per week. Compounded tirzepatide is listed starting at $50 per week; pricing depends on dose.Sources: [6]
- Weight-loss billing
- Weight-loss medication is advertised as pay-per-vial when patients decide to reorder, without a subscription, membership or automatic refill.Sources: [5]
- Follow-up access
- The FAQ promises text check-ins at least every two weeks, optional video follow-ups and typical clinician replies within about 24 hours Monday through Friday.Sources: [4]
- Payment boundaries
- The terms describe purchased products as nonrefundable and say Contour Health does not participate in Medicare, Medicaid or private health insurance plans.Sources: [3]
Start with the vial, not the advertised month
Contour Health’s homepage advertises weight loss from $120 per month at the starting dose, with price determined by dose. Its weight-loss table instead presents compounded semaglutide starting at $30 per week and compounded tirzepatide starting at $50 per week. Elsewhere on that same page, a calculator presents semaglutide from $25 per week. The documentation does not resolve which semaglutide starting figure would apply to a particular patient. None should be treated as a universal final charge.
The purchase unit matters just as much. One note describes medication sold in two-month vials; another says a vial typically lasts six to 14 weeks depending on dose. Those descriptions do not establish a fixed supply quantity or minimum commitment. Contour says the free consultation confirms the exact dose and cost before payment. Ask for the prescribed product, vial volume, concentration, anticipated duration and full charge together, rather than converting a weekly advertisement into an assumed monthly bill.
The table below organizes the differences worth resolving. These are published representations, not independently verified quotes. A useful follow-up is to ask how the next vial’s price would be determined if the prescription changes. Our guide to price questions beyond the monthly amount offers a framework for recording the answer without assuming a price lock.
| Published item | What Contour says | Question before payment |
|---|---|---|
| Homepage weight-loss offer | From $120/month at the starting dose | Which medication and vial does this represent? |
| Compounded semaglutide table | Starting at $30/week; dose-dependent | What is my total vial charge? |
| Semaglutide calculator | From $25/week | Why does this differ from the table? |
| Compounded tirzepatide table | Starting at $50/week; dose-dependent | What presentation and duration does my quote cover? |
| Vial duration | Two months in one note; typically 6–14 weeks elsewhere | What duration is expected for my prescribed vial? |
Identify who provides care and who supplies the medicine
The terms identify Desert Contour LLC, doing business as Contour Health, as the website’s owner and operator. They also say Contour is not a pharmacy or prescription-fulfillment warehouse: it facilitates connections with pharmacies that dispense and deliver prescriptions. The homepage names Strive Pharmacy as the business that compounds and fills prescriptions and describes it as a U.S. 503A compounding pharmacy. Contour says it does not manufacture medication. These separate roles matter when a question concerns prescribing versus a dispensed product.
For clinical leadership, the weight-loss page names Melissa Musso, NP, as leading clinical care and Dr. Laarni Gonzales-Naval as medical director. It says board-certified nurse practitioners handle dosing and check-ins. The FAQ promises assignment to a professional licensed in the patient’s state and continuity with that same professional. These are provider statements, not independent credential verification. Ask who will conduct your appointment, who covers absences and which organization should receive a prescription or pharmacy complaint.
Contour’s broader catalog includes NAD+, sermorelin and hair-loss treatments involving finasteride and minoxidil, all described as subject to individualized assessment. Their presence should not blur the particular product under discussion for weight management. The site’s pharmacy accreditation and sterile-compounding statements are likewise claims, not proof of a particular patient’s outcome. Before comparing offers, use questions about the medicine itself to distinguish the active ingredient, formulation and dispensing pharmacy.
Use the consultation to clarify evaluation, not assume approval
The first consultation takes place by Zoom with a licensed clinician who reviews health history, discusses goals and determines whether a prescription is appropriate. Contour advertises this consultation as free. Patients need internet access, a camera, microphone and the Zoom application on a smartphone, tablet or computer. Its terms also require an informed-consent agreement before telehealth services. A booked consultation therefore represents an evaluation opportunity, not a promise of medication or an already-established treatment plan.
Contour’s FAQ says there is no required BMI to begin the process and that no laboratory work is required before starting treatment. It also says medical necessity and appropriateness are assessed individually. The FAQ also says GLP-1s are generally not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or for those who are pregnant or breastfeeding; the provider reviews the patient’s full history before prescribing. These statements describe Contour’s intake process; they do not establish that every applicant qualifies or that additional evaluation could never be appropriate. Ask what records the clinician wants, how existing conditions and medications will be reviewed, and what findings could change the proposed plan or require care elsewhere.
For geography, Contour says it treats patients in 46 states, excluding Michigan, Mississippi, Kentucky and Arkansas; this licensing representation was not independently verified. Age language is inconsistent: the FAQ advertises access from age 15 with parental consent and oversight for minors, while the terms limit services to people who have reached their jurisdiction’s legal age of majority. Adults should confirm current state availability, and families should not rely on the FAQ alone to resolve that age conflict.
Ask what included follow-up looks like on a difficult day
Contour says its medication price includes the consultation, clinician time, individualized prescribing, check-ins and shipping. Its FAQ makes the follow-up schedule more concrete: text contact at least every two weeks, with patients welcome to reach out more often and request a video follow-up at any time. Those details offer more preparation value than a broad promise of support. Ask who initiates scheduled check-ins, how missed messages are handled and how the clinician assesses response beyond arranging another order.
The stated typical response time is about 24 hours Monday through Friday. The FAQ explicitly says clinicians take weekends off and directs urgent concerns to the clinic. That is not a promise of continuous clinician availability. Contour publishes a clinician text line, (435) 705-5696, and a separate office number for technical or logistical matters, (435) 414-0360, reachable by call or text. Save both, while asking which route is appropriate when symptoms and delivery questions overlap.
The public information does not establish a detailed weekend clinical-coverage arrangement or a guaranteed response deadline. Before enrolling, ask what happens when the usual clinician is unavailable and what concerns require another care setting rather than waiting for a message. Our guide to support after the first prescription can help turn the published contact promises into practical questions. Follow-up access should be understood as a care process, not simply an item included in the price.
Separate the weight-loss reorder from subscription terms
For weight loss, Contour’s homepage is explicit: patients pay for medication by the vial when they decide to reorder, without a subscription, membership or automatic refill. The FAQ describes a clinician discussion before each refill to review progress and determine the next vial size based on the current prescription and care plan. Payment is processed and the refill ordered after that decision. This is a different structure from a recurring monthly membership, even though advertising uses weekly or monthly price figures.
Other programs have different rules. Hair-loss treatment is advertised at $148 every three months for a daily tablet, presented as $49 per month, or $189 quarterly for a topical, presented as $63 per month. Each charge triggers a three-month supply. The first three-month supply is the minimum commitment; afterward, cancellation requires emailing reception@contourhealthrx.com at least 30 days before the next quarterly charge, without a cancellation fee. Those rules should not automatically be transferred to weight-loss purchases.
The general terms nevertheless contemplate certain subscriptions with three consecutive months of service, automatic billing and at least 30 days’ cancellation notice after the initial commitment. Ask Contour to confirm in writing which terms govern your particular order, especially if purchasing more than one program. Separately, the terms say all purchased products are nonrefundable. Choosing not to reorder is not the same as obtaining a refund for a vial already purchased.
Clarify insurance, account payments and outside-pharmacy costs
Contour’s terms say it does not participate in federal or state healthcare programs, including Medicare and Medicaid, or in private health insurance plans. They assign financial responsibility for products and services to the patient. That makes the direct-payment quote central to comparison. Do not assume an insurance card will reduce the advertised vial price, or that an insurer’s coverage of another weight-management product means it covers this purchase. Coverage questions need a separate answer from the health plan.
The company accepts HSA and FSA payments through associated credit or debit cards, but explicitly does not guarantee that the account administrator will approve the purchase as an eligible expense. It says it will provide an itemized receipt and that the treating clinician may supply a letter of medical necessity on request. Ask what documentation is available before relying on reimbursement. Card acceptance and a supporting letter do not, by themselves, establish an administrator’s approval.
There is also a pharmacy-channel boundary to the bundled offer. If a prescription is unavailable through partner pharmacies, the terms say Contour will send it to a pharmacy selected by the patient, who must arrange pickup or delivery and pay the medication cost. Ask whether the quoted amount applies only to the partner-pharmacy route and whether anything remains payable to Contour if an outside pharmacy becomes necessary. The public documentation does not establish a universal price for that alternative.
Plan for delivery questions before the package arrives
Contour’s FAQ says medication ships directly from its pharmacy partner and typically arrives at home within three to five business days once prescribed. That is an advertised arrival window, not merely a dispatch estimate, but it is not a separately documented timeline for the initial clinical evaluation or pharmacy preparation. Ask when tracking becomes available and whom to contact if the shipment stalls. The homepage says injectable orders include the supplies needed to use them.
The terms warn that partner-pharmacy prescriptions may not come in child-resistant packaging. Ask about the actual container and pharmacy storage instructions before delivery, particularly where children could access a package. Another unresolved boundary concerns costs: the site advertises included shipping, while general terms allow shipping and handling charges disclosed at purchase and applicable taxes. Confirm the checkout total. The consulted documentation also does not explain exceptions to the nonrefund policy for damage, fulfillment errors or shipping problems.
FDA guidance adds an important delivery precaution: do not use an injectable GLP-1 product that arrives warm or with inadequate refrigeration; contact the provider or dispensing pharmacy. This is general FDA advice, not evidence that Contour shipments have had that problem. Establish the reporting route beforehand using questions about delivery problems, including what information the pharmacy needs and how replacement or other resolution would be handled.
Distinguish the offered preparation from evidence about approved drugs
Contour acknowledges that compounded medications are not FDA approved and that FDA does not review them for safety or effectiveness. Its weight-loss page also states that the trial results it presents concern FDA-approved branded medications. That distinction is essential: an advertisement discussing semaglutide or tirzepatide research does not establish measured outcomes for Contour patients or for its compounded preparations. FDA approval attaches to a specific product, not to the clinic arranging treatment.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. This recommendation is a useful consultation question, not a categorical legal conclusion about Contour. Ask why the proposed compounded preparation fits the clinician’s assessment and what approved alternatives were considered. Nonapproval alone does not demonstrate clinical inequivalence, and the company’s pharmacy-quality statements do not substitute for product-specific clinical evidence.
FDA also reports errors in measuring or administering compounded medicines, including some associated with hospitalization. Patients should clarify instructions with their prescriber or pharmacist rather than derive a dose from a review. NIDDK advises discussing current medicines, supplements, allergies, health conditions and pregnancy plans with the clinician. These discussions should accompany questions about response, side effects and ongoing care; neither a low advertised price nor a completed intake establishes individual treatment suitability.
Questions & answers
Is the first Contour Health consultation free?
Contour advertises a free consultation and says the exact prescription and cost are confirmed before payment. The initial visit is by Zoom. Ask for the complete vial quote afterward; a free evaluation does not mean free medication or a guaranteed prescription.
Does Contour automatically refill weight-loss medication?
Its published weight-loss model says no automatic refills, subscriptions or memberships. Reordering involves contacting the clinician, reviewing progress and agreeing on the next vial before payment and ordering. Confirm that your checkout documents reflect this model rather than another program’s subscription rules.
Which semaglutide starting price should I expect?
The public page does not settle that question: its table says starting at $30 per week, while its calculator says from $25 per week. Both are advertising figures, not a universal vial quote. Request the applicable price, presentation and expected duration in writing before paying.
Can I reach my clinician on weekends?
Contour says typical clinician replies take about 24 hours on weekdays and explicitly notes that clinicians take weekends off. It directs urgent concerns to the clinic but does not document a guaranteed weekend clinical-response arrangement. Ask for that plan rather than assuming round-the-clock access.
Does using an HSA or FSA guarantee reimbursement?
No. Contour accepts associated payment cards but says administrator approval is not guaranteed. It offers an itemized receipt, and a clinician may provide a medical-necessity letter on request. Confirm requirements with the account administrator before assuming the expense will qualify.
What if my vial arrives damaged or inadequately refrigerated?
Ask Contour and the dispensing pharmacy about their resolution process before ordering; the reviewed documentation does not specify refund exceptions for delivery problems. FDA advises not using injectable GLP-1 medication that arrives warm or inadequately refrigerated and contacting the provider or pharmacy.
Our assessment
Contour Health documents a comparatively clear weight-loss ordering concept: a free consultation, clinician follow-up and medication purchased by the vial rather than automatic renewal. Named clinical leadership, pharmacy identification and published contact numbers also help patients prepare. The unresolved details are consequential, however: competing semaglutide starting prices, differing vial-duration descriptions, broad nonrefund language and unclear delivery-problem remedies. A useful next step is a written, patient-specific quote and care plan that identifies the preparation, pharmacy, full charge, expected vial duration and support responsibilities. That would clarify the offer without treating its commercial promises as independently verified clinical outcomes.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.